Blinded Dry Mouth Spray Crossover Study

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

129 participants

Study Classification

INTERVENTIONAL

Study Start Date

2021-01-14

Study Completion Date

2023-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

To identify the effectiveness of two mouth sprays at relieving symptoms of xerostomia in patients who have received radiation for carcinoma of the head and neck.

To assess patient quality of life and mouth acidity following use of two mouth sprays meant to relieve symptoms of xerostomia in patients who have received radiation for carcinoma of the head and neck.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Salivary Gland Surgery Before Radiation Therapy in Preventing Radiation-Caused Xerostomia in Patients With Head and Neck Cancer

NCT00068237

Head and Neck Cancer Radiation Toxicity Xerostomia

COMPLETED PHASE2

Pilocarpine in Preventing Mucositis and Dry Mouth in Patients Receiving Radiation Therapy for Head and Neck Cancer

NCT00003139

Head and Neck Cancer Oral Complications

COMPLETED PHASE3

A Study of Patients With Dry Mouth and Sticky Saliva During Radiotherapy

NCT02687087

Xerostomia

COMPLETED NA

A Trial Looking at Treating Dry Mouth After Radiotherapy for Head and Neck Cancer

NCT02941276

Xerostomia Head and Neck Neoplasms

COMPLETED NA

Repeated Mesenchymal Stem Cell Therapy for Radiation-Induced Hyposalivation and Xerostomia in Head and Neck Cancer Survivors

NCT07290946

Xerostomia Due to Hyposecretion of Salivary Gland Xerostomia Due to Radiotherapy Sjögren´s Syndrome

NOT_YET_RECRUITING PHASE2

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Investigators have observed that patients at the University of Pittsburgh Medical Center Head and Neck Survivorship clinic with symptoms of radiation-induced xerostomia expressed verbal preference for Biotene and Refresh mouth sprays (spray form of mouthwash) compared to other oral products such as gel, toothpaste, and chewing gum. Investigators have designed this study to specifically assess the effectiveness of mouth sprays on xerostomia in patients who have completed radiation for head and neck carcinoma. While there have been clinical trials to evaluate the effectiveness of Biotene oral products for xerostomia, Refresh mouthwash/mouth spray is a newer oral rinse formula that has not undergone any randomized controlled trials to evaluate its efficacy compared to other agents of its kind. The investigators have put forward this randomized controlled trial to compare the efficacy of both sprays to each other and to water. Biotene spray is cleared by the FDA as a medical device product. Currently, Refresh mouth spray falls under the FD\&C Act.

There is preliminary data on the effectiveness of Biotene mouthwash for xerostomia in patients who have had radiation of the head and neck. A phase II study of Biotene products (mouthwash, chewing gum, and toothpaste) were effective at improving many symptoms of post-irradiation xerostomia. Numerous other studies have shown that mouthwash and topical dry mouth products improve xerostomia symptoms.

Xerostomia, or mouth dryness, is a frequent side effect of head and neck cancer radiation therapy, as the salivary glands are often damaged during therapy. Radiation therapy can be successful in treating cancer, but post-irradiation xerostomia can cause oral discomfort as well as issues with eating, speech, and oral hygiene, leading to significantly decreased quality of life. While treatment of xerostomia has limited benefit, various mouthwashes have led to major symptomatic improvement in some patients. This study will add to existing literature by commenting on efficacy of a popular and established mouth spray used for xerostomia as well as a new mouth spray that has not been compared to existing formulas. A double-blinded randomized controlled trial evaluating these mouth sprays will add information about value of both formulas for head and neck carcinoma survivors with radiation-induced xerostomia.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Xerostomia Head and Neck Cancer Xerostomia Following Radiotherapy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

OTHER

Blinding Strategy

QUADRUPLE

Participants Caregivers Investigators Outcome Assessors

Both subjects and clinicians will be blinded to Mouth Spray A and Mouth Spray B.

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Biotene Spray, followed by Refresh Spray

The Biotene Spray followed by Refresh Spray Arm will be asked to complete a 2 week trial using Biotene Spray first, then will be asked to complete a 2 week trial using Refresh Spray second. (after the appropriate 1 week washout periods have been completed)

Group Type OTHER

Remineralizing Extreme Dry Mouth Spray with Xylitol

Intervention Type OTHER

oral hydrating spray

Alcohol-Free Moisturizing Dry Mouth Spray

Intervention Type DEVICE

oral hydrating spray

Refresh Spray, followed by Biotene Spray

The Refresh Spray, followed by Biotene Spray Arm will be asked to complete a 2 week trial using Refresh Spray first, then will be asked to complete a 2 week trial using Biotene Spray second. (after the appropriate 1 week washout periods have been completed)

Group Type OTHER

Remineralizing Extreme Dry Mouth Spray with Xylitol

Intervention Type OTHER

oral hydrating spray

Alcohol-Free Moisturizing Dry Mouth Spray

Intervention Type DEVICE

oral hydrating spray

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Remineralizing Extreme Dry Mouth Spray with Xylitol

oral hydrating spray

Intervention Type OTHER

Alcohol-Free Moisturizing Dry Mouth Spray

oral hydrating spray

Intervention Type DEVICE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Refresh Oral Hydrating Spray Biotene

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* biopsy-proven oral cavity, oropharynx, larynx, and hypopharynx carcinoma
* who received primary radiation with curative intent (\>50 Gray in 20 fractions)
* radiation treatment completed greater than 6 months ago
* who endorse xerostomia

Exclusion Criteria

* evidence of metastasis or recurrent disease
* Current use of pilocarpine, antidepressants, anticholinergic drugs, or any other medication that has an effect on salivation
* those who have documented medical conditions associated with xerostomia such as Sjogren's Syndrome
* those who use oral inhalants for the treatment of respiratory disease

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No